Two Sigma Securities, LLC Acer Therapeutics Inc. Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.57 - $1.28 $1,096 - $2,461	1,923 Added 7.81%	26,533 $21,000
Q2 2023 Aug 14, 2023	BUY	$0.75 - $1.14 $18,457 - $28,055	24,610 New	24,610 $22,000
Q4 2022 Feb 14, 2023	BUY	$1.13 - $4.15 $22,314 - $81,950	19,747 New	19,747 $49,000
Q1 2022 May 16, 2022	SELL	$1.98 - $2.98 $24,900 - $37,476	-12,576 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.88 - $2.9 $23,642 - $36,470	12,576 New	12,576 $29,000
Q3 2020 Nov 16, 2020	SELL	$2.16 - $5.41 $36,685 - $91,883	-16,984 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.53 - $4.53 $25,985 - $76,937	16,984 New	16,984 $58,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.